Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecovirimat for Monkeypox Virus Disease (PALM 007)
NCT05559099Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tecovirimat in mpox, sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2022; status: completed.
02
Drugs
tecovirimat
03
Conditions
mpox
Beyond the preview
Go deeper on NCT05559099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05559099.